Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Psoriasis Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Psoriasis Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 TNF Inhibitors
      • 1.3.3 Phosphodiesterase Inhibitors
      • 1.3.4 Interleukin Blockers
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Psoriasis Treatment Market Share by Application (2019-2025)
      • 1.4.2 Oral
      • 1.4.3 Tropical
      • 1.4.4 Injectable
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Psoriasis Treatment Production Value 2014-2025
      • 2.1.2 Global Psoriasis Treatment Production 2014-2025
      • 2.1.3 Global Psoriasis Treatment Capacity 2014-2025
      • 2.1.4 Global Psoriasis Treatment Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Psoriasis Treatment Market Size CAGR of Key Regions
      • 2.2.2 Global Psoriasis Treatment Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Psoriasis Treatment Capacity by Manufacturers
      • 3.1.2 Global Psoriasis Treatment Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Psoriasis Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Psoriasis Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Psoriasis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Psoriasis Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Psoriasis Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Psoriasis Treatment Market
    • 3.6 Key Manufacturers Psoriasis Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 TNF Inhibitors Production and Production Value (2014-2019)
      • 4.1.2 Phosphodiesterase Inhibitors Production and Production Value (2014-2019)
      • 4.1.3 Interleukin Blockers Production and Production Value (2014-2019)
      • 4.1.4 Others Production and Production Value (2014-2019)
    • 4.2 Global Psoriasis Treatment Production Market Share by Type
    • 4.3 Global Psoriasis Treatment Production Value Market Share by Type
    • 4.4 Psoriasis Treatment Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Psoriasis Treatment Consumption by Application

    6 Production by Regions

    • 6.1 Global Psoriasis Treatment Production (History Data) by Regions 2014-2019
    • 6.2 Global Psoriasis Treatment Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Psoriasis Treatment Production Growth Rate 2014-2019
      • 6.3.2 United States Psoriasis Treatment Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Psoriasis Treatment Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Psoriasis Treatment Production Growth Rate 2014-2019
      • 6.4.2 European Union Psoriasis Treatment Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Psoriasis Treatment Import & Export
    • 6.5 China
      • 6.5.1 China Psoriasis Treatment Production Growth Rate 2014-2019
      • 6.5.2 China Psoriasis Treatment Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Psoriasis Treatment Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Psoriasis Treatment Consumption by Regions

    • 7.1 Global Psoriasis Treatment Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Psoriasis Treatment Consumption by Type
      • 7.2.2 United States Psoriasis Treatment Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Psoriasis Treatment Consumption by Type
      • 7.3.2 European Union Psoriasis Treatment Consumption by Application
    • 7.4 China
      • 7.4.1 China Psoriasis Treatment Consumption by Type
      • 7.4.2 China Psoriasis Treatment Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Psoriasis Treatment Consumption by Type
      • 7.5.2 Rest of World Psoriasis Treatment Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Novartis International AG
      • 8.1.1 Novartis International AG Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Psoriasis Treatment
      • 8.1.4 Psoriasis Treatment Product Introduction
      • 8.1.5 Novartis International AG Recent Development
    • 8.2 Johnson & Johnson
      • 8.2.1 Johnson & Johnson Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Psoriasis Treatment
      • 8.2.4 Psoriasis Treatment Product Introduction
      • 8.2.5 Johnson & Johnson Recent Development
    • 8.3 Pfizer Inc.
      • 8.3.1 Pfizer Inc. Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Psoriasis Treatment
      • 8.3.4 Psoriasis Treatment Product Introduction
      • 8.3.5 Pfizer Inc. Recent Development
    • 8.4 Merck and Co. Inc.
      • 8.4.1 Merck and Co. Inc. Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Psoriasis Treatment
      • 8.4.4 Psoriasis Treatment Product Introduction
      • 8.4.5 Merck and Co. Inc. Recent Development
    • 8.5 AbbVie and Amgen
      • 8.5.1 AbbVie and Amgen Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Psoriasis Treatment
      • 8.5.4 Psoriasis Treatment Product Introduction
      • 8.5.5 AbbVie and Amgen Recent Development
    • 8.6 Eli Lilly
      • 8.6.1 Eli Lilly Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Psoriasis Treatment
      • 8.6.4 Psoriasis Treatment Product Introduction
      • 8.6.5 Eli Lilly Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Psoriasis Treatment Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Psoriasis Treatment Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Psoriasis Treatment Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Psoriasis Treatment Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Psoriasis Treatment Production Forecast by Type
      • 9.7.2 Global Psoriasis Treatment Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Psoriasis Treatment Sales Channels
      • 10.2.2 Psoriasis Treatment Distributors
    • 10.3 Psoriasis Treatment Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals directing skin cells to grow too quickly.
      Globally North America is the largest market of global psoriasis treatment. Europe is the second largest market for global psoriasis treatment. However the developing market is Asia Pacific that will be the fastest growing region and will be the key to the future.
      In 2019, the market size of Psoriasis Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Psoriasis Treatment.

      This report studies the global market size of Psoriasis Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Psoriasis Treatment production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Novartis International AG
      Johnson & Johnson
      Pfizer Inc.
      Merck and Co. Inc.
      AbbVie and Amgen
      Eli Lilly
      ...

      Market Segment by Product Type
      TNF Inhibitors
      Phosphodiesterase Inhibitors
      Interleukin Blockers
      Others

      Market Segment by Application
      Oral
      Tropical
      Injectable

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Psoriasis Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Psoriasis Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Psoriasis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now